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The recent commitment of the Obama
administration to establish the Global
Health Initiative, which is expected to
increase to over US$100 million annually
for neglected tropical disease (NTD)
control, provides the most significant
investment and opportunity for the global
control of NTDs to date [1,2]. These
investments, together with commitments
by the British Department for Internation-
al Development, the World Bank, and
several key private philanthropies, includ-
ing the Bill & Melinda Gates Foundation,
must be guided by a strong evidence-based
approach. First, the problem, and the
resources required to tackle it, need to be
clearly quantified. Second, mass drug
administration (MDA) should be optimally
targeted to communities with the highest
prevalence of infection and presumed
greatest morbidity [3,4]. Furthermore,
for diseases targeted for elimination,
including lymphatic filariasis (LF) and
onchocerciasis, it will become increasingly
important to determine whether MDA
can be stopped, and, if so, when and
where. In the case of schistosomiasis, as
control is scaled up, there is the additional
requirement of determining when and
where to shift praziquantel treatment from
once per year to less frequent intervals.
New Diagnostic Tools
Better diagnostic tools and new methods
of surveillance provide more affordable
and realistic opportunities to improve the
planning, monitoring, and evaluation of
NTD control. Diagnosis of onchocerciasis
was previously based on detection of
microfilariae in skin snips, but this invasive
technique is gradually being replaced by
antibody-based tests, which can provide a
simple and rapid method of diagnosis
[5,6]. The development of a simple and
rapid antigen detection test for Wuchereria
bancrofti antigenaemia, based on the im-
muno-chromatographic test (ICT card
test), revolutionized LF surveys since it
avoided the need to collect blood at night
and the time-consuming preparation and
examination of blood slides [7]. Ongoing
efforts are investigating similar rapid
antigen detection tests for schistosomiasis
[8]. This new generation of diagnostics
provides a sound foundation for develop-
ing reliable, up-to-date maps of the
distribution of different NTDs to guide
and target resources efficiently. Without
such maps, the journey of NTD control
will be difficult.
Mapping of NTDs
In the past, national reporting on NTDs
has been incomplete and unreliable be-
cause of weak disease surveillance systems,
often necessitating dedicated surveys to be
undertaken. Perhaps the first attempt to
develop evidence-based maps of any NTD
was that of the African Programme for
Onchocerciasis Control (APOC), which
developed the rapid epidemiological map-
ping of onchocerciasis (REMO) approach
to quickly and cheaply identify priority
areas for community-directed treatment
with ivermectin (CDTI) and estimate the
number of individuals requiring treatment
[9]. This approach stratifies a country into
areas that are suitable and unsuitable for
transmission, based on known geographic
factors, and within suitable areas imple-
ments rapid assessment of communities by
screening individuals for onchocercal nod-
ules. In Africa, a total of 23 countries have
been mapped for onchocerciasis. As coun-
tries have been successful in controlling
onchocerciasis, many are now conducting
new REMO assessments to provide up-
dated maps. For LF, the rapid geograph-
ical assessment of Bancroftian filariasis
(RAGFIL) method [10] using ICT card
tests enabled large-scale assessments of the
boundaries of filaria-endemic areas for
identifying areas requiring MDA (with
albendazole and ivermectin or diethylcar-
bamazine-citrate) [11]. In 2009, all en-
demic countries in the World Health
Organization (WHO)-defined regions of
the Eastern Mediterranean, South-East
Asia, and Western Pacific have completed
mapping, whilst in Africa, 37 of 39
endemic countries have completed or are
in the process of mapping, with only Chad
and Eritrea yet to start [12]. In the case of
schistosomiasis, one of the first steps of the
Schistosomiasis Control Initiative (SCI) in
designing country programmes was to
conduct national prevalence surveys of
schistosomiasis to identify communities
and districts requiring mass treatment with
praziquantel [13,14]. Outside SCI-sup-
ported countries, national surveys of
schistosomiasis and soil-transmitted hel-
minth (STH) infections are often scarce
and ad-hoc, with the exception of some
dedicated surveys, such as those supported
by the Carter Center [15,16] and most
recently by countries supported by the
NTD Initiative of the US Agency for
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Despite these efforts, there remains a
considerable mapping requirement to
support global NTD control. Also, it is
little appreciated that as control is success-
ful in reducing transmission, there will be
an increasing requirement to conduct
mapping surveys to assess whether to stop
MDA or switch to less frequent treatment.
New Mapping Technologies
Future data collection efforts should
take advantage of recent advances in
recording and processing data and con-
verting data into maps. Increasingly,
surveys utilize electronic data capture
systems, mainly based on the use of
personal digital assistants (PDAs) but also
small laptops, to enter data at the point of
collection [18] and almost instantaneously
transmit the information to a central
database using mobile phone technology
[19]. Once data have been collected and
collated, geographical information systems
(GIS) provide a ready framework in which
to manage and display the data. The
distribution of NTDs is particularly sensi-
tive to climatic and environmental factors
because of the vulnerability of vectors,
intermediate hosts, and free-living stages.
The GIS frameworks allow ready com-
parison between disease patterns and
environmental data, while remote sensing
(RS) technologies can use high-resolution
satellite data to provide estimates of such
variables as temperature, vegetation (as a
proxy for various environmental factors),
and humidity [20]. The relationships
between observed infection patterns and
environmental factors can be investigated
using both traditional and spatially explicit
statistical approaches [21], allowing the
spatial distributions of infection prevalence
to be predicted in unsurveyed areas. Such
analyses are increasingly adopting a
Bayesian approach to statistical inference
that provides a robust method for mea-
suring uncertainty in prediction [22,23].
Finally, it is perhaps worth emphasizing
that this journal is itself an example of the
power of the new technologies, since the
open-access format permits the data,
analyses, and predictions to be published
in a way that maximizes access to the
information.
Current Global Mapping
Resources
Although many surveys of different
NTDs have been conducted and many
more are planned, the survey data are only
useful if available in a form that is
accessible to policy-makers and the man-
agers of public health programmes. At
present the most detailed maps available
are for onchocerciasis, LF, and schistoso-
miasis. For onchocerciasis, the country-
level REMO maps, which highlight the
areas where CDTI is needed, are made
available through APOC’s Web site [24].
For schistosomiasis, the most complete
global resource remains the 1987 Atlas of
the Global Distribution of Schistosomiasis [25],
now available online [26]. For each
country, a map is presented that shows
the presence or absence of schistosomiasis.
Although these maps represent an impor-
tant early source of information, the data
are at best 23 years old and do not include
the wealth of prevalence data collected
more recently.
The preventive chemotherapy (PCT)
databank was developed by WHO as a
tool to map progress on the implementa-
tion of NTD control efforts targeting LF,
schistosomiasis, and STH infections [27].
The PCT databank includes country
profiles that present the estimated popula-
tion at risk of infection and requiring PCT
and, where available, data on treatment
coverage for each NTD [28]. However,
the PCT databank only includes data as
reported to WHO and excludes survey
information from other sources, such as
data collected by academic researchers,
nongovernmental organizations (NGOs),
and other partners. The data are present-
ed at administrative level 1 (province or
region) and the derived maps inevitably
cannot capture the fine-scale heteroge-
neity of infection patterns, so they tend to
overestimate the numbers of individuals
requiring treatment.
A Global Atlas of Helminth
Infection
In an attempt to provide open access to
up-to-date information on schistosomiasis
and STH infections, a project has been
undertaken to develop a Global Atlas of
Helminth Infection (GAHI) [29,30]. The
overall goal of this project is to provide an
open-access, global information resource
on the distribution of STH and schistoso-
miasis, with the specific aims of 1)
describing the global distribution and
prevalence of infection of each species
and 2) highlighting geographical areas for
which further survey information is re-
quired. The maps are grounded in struc-
tured searches of the formal and grey
literature for suitable survey data that are
then collated into a single database,
according to specified inclusion criteria.
The eligible surveys are geo-positioned
using electronic sources and maps are then
developed using GIS. To date, more than
10,000 prevalence surveys have been
identified, catalogued, and mapped. The
potential usefulness of the data to identify
‘‘at risk’’ populations for which data are
scarce is enhanced by using Bayesian
model-based geostatistics [23] to predict
the prevalence of infection with each
species in as yet unsurveyed areas.
The GAHI Web site will be launched
on August 12, 2010 at http://www.
thiswormyworld.org/. The Web site al-
lows users to visualize the assembled data
and models. Three types of maps are
presented for every country where these
infections occur: (i) a Survey Data Map
showing the prevalence of infection based
on survey data; (ii) a Predictive Risk Map
showing the probability that infection
prevalence warrants MDA, according to
recommended WHO thresholds; and (iii) a
Control Planning Map showing which dis-
tricts require MDA treatment or where
further surveys would be helpful in
defining risk.
As the URL suggests, inspiration for this
project comes from the work of the
American parasitologist Norman Stoll,
who, during his 1946 presidential address
to the American Society of Parasitologists,
posed the question, just how much human
helminthiasis is there in the world? The
resultant paper, This Wormy World [31],
was the first systematic attempt to measure
the worldwide impact of human parasitism
by helminths and provides the foundation
for subsequent attempts to define the
burden of NTDs [32]. Building on the
GAHI, an ongoing project is developing a
Global Atlas of Trachoma, expanding
earlier attempts to the map the global
distribution of trachoma [33]. This work is
intended to provide an evidence base for
allocating resources for trachoma control,
including surgery and administration of
Zithromax [35].
Conclusion
Accurate and up-to-date maps of differ-
ent NTDs can help improve the precision
of decision-making in NTD control. They
can help increase the reliability of esti-
mates of disease burden, for example, as
part of the ongoing revision of the Global
Burden of Disease study [34]. The maps
can also establish a baseline against which
to measure the impact of NTD control
efforts. Finally, they can provide an
important planning tool for national
control programmes. Considerable effort
is required to develop an integrated NTD
atlas, necessitating cooperation and col-
www.plosntds.org 2 July 2010 | Volume 4 | Issue 7 | e779laboration of the different NTD commu-
nities. We hope the Global Atlas of
Helminth Infection will encourage this interaction and help progress towards an
open access Global Atlas of NTDs.
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